{"id":"https://openalex.org/W2113517664","doi":"https://doi.org/10.1016/0376-8716(95)01189-7","title":"Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing","display_name":"Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing","alternate_titles":[],"publication_year":1995,"publication_date":"1995-11-01","ids":{"openalex":"https://openalex.org/W2113517664","doi":"https://doi.org/10.1016/0376-8716(95)01189-7","mag":"2113517664","pmid":"https://pubmed.ncbi.nlm.nih.gov/8746921"},"language":"en","primary_location":{"id":"doi:10.1016/0376-8716(95)01189-7","doi":"https://doi.org/10.1016/0376-8716(95)01189-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0376-8716(95)01189-7","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2113517664"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/0376-8716(95)01189-7","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Rolley E. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Rolley E. Johnson","raw_affiliation_strings":["Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224-6823, USA","Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21224-6823, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]},{"raw_affiliation_string":"Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA,","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064551545","display_name":"Thomas Eissenberg","orcid":"https://orcid.org/0000-0002-8277-5437","observed_orcids":["https://orcid.org/0000-0002-8277-5437"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas Eissenberg","raw_affiliation_strings":["Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009013887","display_name":"Maxine L. Stitzer","orcid":"https://orcid.org/0000-0002-1767-9561","observed_orcids":["https://orcid.org/0000-0002-1767-9561"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maxine L. Stitzer","raw_affiliation_strings":["Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017911936","display_name":"Eric C. Strain","orcid":"https://orcid.org/0000-0001-8482-5461","observed_orcids":["https://orcid.org/0000-0001-8482-5461"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Eric C. Strain","raw_affiliation_strings":["Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041746724","display_name":"Ira A. Liebson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ira A. Liebson","raw_affiliation_strings":["Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084389493","display_name":"George E. Bigelow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"George E. Bigelow","raw_affiliation_strings":["Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"],"apc_list":{"value":4380,"currency":"USD","value_usd":4380},"apc_paid":{"value":4380,"currency":"USD","value_usd":4380},"fwci":4.3966,"has_fulltext":false,"cited_by_count":94,"citation_normalized_percentile":{"value":0.93668229,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"40","issue":"1","first_page":"27","last_page":"35"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":1.0},{"id":"https://openalex.org/keywords/opioid-use-disorder","display_name":"opioid use disorder","score":0.9959999918937683},{"id":"https://openalex.org/keywords/alternate-day-dosing","display_name":"alternate-day dosing","score":0.9629999995231628},{"id":"https://openalex.org/keywords/daily-dosing","display_name":"daily dosing","score":0.847000002861023},{"id":"https://openalex.org/keywords/sublingual-administration","display_name":"sublingual administration","score":0.8109999895095825},{"id":"https://openalex.org/keywords/treatment-retention","display_name":"treatment retention","score":0.9190000295639038},{"id":"https://openalex.org/keywords/opioid-withdrawal-symptoms","display_name":"opioid withdrawal symptoms","score":0.5090000033378601},{"id":"https://openalex.org/keywords/cocaine-use","display_name":"cocaine use","score":0.8450000286102295},{"id":"https://openalex.org/keywords/outpatient-care","display_name":"outpatient care","score":0.382999986410141}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.9196310043334961},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.9134989976882935},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7732680439949036},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.660773515701294},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5939688086509705},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5826536417007446},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4723050594329834},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.45296573638916016},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2438657283782959},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009292","descriptor_name":"Narcotic Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009460","descriptor_name":"Neurologic Examination","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013375","descriptor_name":"Substance Withdrawal Syndrome","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D015813","descriptor_name":"Substance Abuse Detection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0376-8716(95)01189-7","doi":"https://doi.org/10.1016/0376-8716(95)01189-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0376-8716(95)01189-7","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},{"id":"pmid:8746921","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8746921","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and alcohol dependence","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1016/0376-8716(95)01189-7","doi":"https://doi.org/10.1016/0376-8716(95)01189-7","is_oa":true,"landing_page_url":"https://doi.org/10.1016/0376-8716(95)01189-7","pdf_url":null,"source":{"id":"https://openalex.org/S109998069","display_name":"Drug and Alcohol Dependence","issn_l":"0376-8716","issn":["0376-8716","1879-0046"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug and Alcohol Dependence","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[{"id":"https://openalex.org/G2774269815","display_name":"BUPRENORPHINE:  EVALUATION FOR IV DRUG ABUSE TREATMENT","funder_award_id":"R18DA006165","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G4058878656","display_name":"HUMAN BEHAVIORAL PHARMACOLOGY OF DRUG ABUSE","funder_award_id":"K05DA000050","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"},{"id":"https://openalex.org/G9000894987","display_name":"Human Behavioral Pharmacology of Substance Abuse","funder_award_id":"T32DA007209","funder_id":"https://openalex.org/F4320337347","funder_display_name":"National Institute on Drug Abuse"}],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1965602674","https://openalex.org/W1968097361","https://openalex.org/W1979184030","https://openalex.org/W1992389336","https://openalex.org/W1995107146","https://openalex.org/W2002091306","https://openalex.org/W2010748920","https://openalex.org/W2029901016","https://openalex.org/W2032212168","https://openalex.org/W2032933468","https://openalex.org/W2035860618","https://openalex.org/W2039276957","https://openalex.org/W2048531018","https://openalex.org/W2058067215","https://openalex.org/W2061161214","https://openalex.org/W2063539450","https://openalex.org/W2064968738","https://openalex.org/W2080180551","https://openalex.org/W2091692004","https://openalex.org/W2097145370","https://openalex.org/W2109905455","https://openalex.org/W2114903378","https://openalex.org/W2133801459","https://openalex.org/W2163859821","https://openalex.org/W2250136567","https://openalex.org/W2259705635","https://openalex.org/W2325657366","https://openalex.org/W2411858615","https://openalex.org/W4238905037"],"related_works":["https://openalex.org/W1995107146","https://openalex.org/W2092356971","https://openalex.org/W2101881212","https://openalex.org/W2083263555","https://openalex.org/W2141882410","https://openalex.org/W2082576323","https://openalex.org/W1968731926","https://openalex.org/W2112174894","https://openalex.org/W2048334325","https://openalex.org/W2048531018"],"abstract_inverted_index":{"Buprenorphine,":[0],"a":[1,33,42,155,204],"mu-opioid":[2],"partial":[3],"agonist,":[4],"has":[5],"demonstrated":[6],"efficacy":[7,167],"for":[8,77,103,116,158],"the":[9,126,142,159,169,190],"treatment":[10,98,134],"of":[11,17,22,47,73,150,181,207],"opioid":[12],"dependence":[13],"comparable":[14],"to":[15,62,84,163,203],"that":[16,192],"methadone.":[18],"The":[19,38],"clinical":[20,45,166],"utility":[21],"buprenorphine":[23,86,187],"would":[24],"be":[25,30,198],"enhanced":[26],"if":[27],"it":[28],"could":[29],"dosed":[31],"on":[32,145],"less":[34,182],"than":[35,183],"daily":[36,48,63,160,184],"basis.":[37],"current":[39],"study":[40],"is":[41],"parallel-group":[43],"outpatient":[44],"trial":[46],"versus":[49],"alternate-day":[50,68,85,194],"dosing":[51,143,161,185,195],"with":[52,125,133,178,186],"8":[53],"mg":[54],"sublingual":[55],"(s.l.)":[56],"buprenorphine.":[57],"Participants":[58],"were":[59,95,118],"randomly":[60],"assigned":[61,83],"(n":[64,69],"=":[65,70],"51)":[66],"or":[67],"48)":[71],"schedules":[72,144],"active":[74],"medication":[75],"administration":[76],"an":[78,193],"11-week":[79],"double-blind":[80],"trial.":[81],"Patients":[82],"received":[87],"placebo":[88],"every":[89],"other":[90],"day.":[91],"Primary":[92],"outcome":[93,120,147],"measures":[94],"retention":[96],"in":[97,200],"and":[99,112,188,201],"urine":[100,113],"specimens":[101,114],"positive":[102,115],"opiates.":[104],"Clinic":[105],"attendance,":[106],"dose":[107,170],"adequacy":[108],"ratings,":[109],"withdrawal":[110],"symptomatology,":[111],"cocaine":[117],"secondary":[119],"measures.":[121],"Neither":[122],"endpoint":[123],"analysis":[124,132],"intent-to-treat":[127],"sample":[128],"nor":[129],"time":[130],"course":[131],"completers":[135],"revealed":[136],"any":[137,146],"statistically":[138],"significant":[139],"differences":[140],"between":[141],"measure.":[148],"Examination":[149],"95%":[151],"confidence":[152],"intervals":[153],"suggested":[154],"non-significant":[156],"trend":[157],"schedule":[162,196],"have":[164],"superior":[165],"at":[168],"tested.":[171],"Nevertheless,":[172],"these":[173],"results":[174],"are":[175],"generally":[176],"consistent":[177],"previous":[179],"studies":[180],"support":[189],"conclusion":[191],"can":[197],"effective":[199],"acceptable":[202],"substantial":[205],"portion":[206],"patients.":[208]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2113517664","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
